Sinohealth Technology Holdings Limited (2361.HK)
HKSE · HKD · Healthcare · Health Information Services
HK$3.96 (-0.38%) as of
Key statistics
- Market cap
- 1.79B
- P/E (TTM)
- 23.29
- EPS (TTM)
- 0.170
- Dividend yield
- 1.79%
- 52-week range
- 3.650 – 5.600
- Beta
- -0.20
- Revenue (TTM)
- 432.68M
- Profit margin
- 16.49%
- Volume
- 1.50k
About Sinohealth Technology Holdings Limited
Sinohealth Technology Holdings Limited provides healthcare solutions for sales and marketing needs of medical product manufacturer clients in Mainland China and internationally. It engages in the research and development, and provision of data insight solutions, data-driven publications and events, and software as a service (SaaS) products; research and development, and operation of Smart Medical Cloud under the business line of SaaS products; management of marketing and promotion services of medicine; operation of SaaS products; provision of internet information and internet data center services; production and publication of videos; and foreign-related market research business. The company also offers precision marketing solutions; and consulting and marketing services. It serves various fields, such as pharmaceutical industry, retail pharmacies, and physical examination and hospitals. Sinohealth Technology Holdings Limited was formerly known as Sinohealth Holdings Limited and changes its name to Sinohealth Technology Holdings Limited in February 2026. The company was founded in 2007 and is headquartered in Guangzhou, China.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Guangzhou, China
- Employees
- 832
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.